Ticker
ENTACompany Name
ENANTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -43.57M | $ -2.04 | 1 | 21.38M |
3/31/2025 | $ -82.24M | $ -3.85 | 1 | 21.36M |
12/31/2024 | $ -96.48M | $ -4.54 | 1 | 21.24M |
9/30/2024 | $ -96.71M | $ -4.57 | 1 | 21.16M |
6/30/2024 | $ -100.33M | $ -4.74 | 1 | 21.18M |
3/31/2024 | $ -113.29M | $ -5.35 | 1 | 21.17M |
12/31/2023 | $ -99.19M | $ -4.7 | 1 | 21.09M |
9/30/2023 | $ -112.21M | $ -5.35 | 1 | 20.97M |
6/30/2023 | $ -106.21M | $ -5.04 | 1 | 21.05M |
3/31/2023 | $ -101.79M | $ -4.84 | 1 | 21.04M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / (Shares WA * Share Factor)
(=) FCFPS
FCFPS for ENANTA PHARMACEUTICALS INC is calculated as follows: FCF [ $ 5.64M ] / (Shares WA [ 19.94M ] * Share Factor [ 1 ])
(=) FCFPS [ $ 0.28 ]
Minimum
Dec 31, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.76K |
---|---|
min | $ -7.96 |
max | $ 8.85 |
average | $ 0.8 |
median | $ 0.29 |
std | $ 2.82 |